Skip to content
OpenCapital
Get started

UiPath PATH Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Europe, Middle East, and Africa33%-5.7%

Other financials

Income statement

See full
Revenue$418.4M+17.3%
Gross profit$341.5M+16.6%
Operating income$28.0M+271%
Net income$22.5M+200%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$633.7M-9.6%
Total debt$83.0M+5.1%
Total equity$1.9B+12.0%
Total assets$2.9B+9.8%

Cash flow

See full
Operating cash flow$131.9M+10.9%
CapEx$2.7M-79.1%
Free cash flow$129.2M+21.7%

Valuation

See full
Market cap$5.46B-18.5%
Enterprise value$4.91B-19.2%
P/E16.7×—
P/S3.3×-1.3×

Profitability

See full
Gross margin83%+0.6pp
Operating margin6%—
Net margin19.6%—
FCF margin22.4%+0.9pp

Returns & leverage

See full
Return on equity18.2%—
Debt / equity0×0.0×
Current ratio2.3×-0.6×